JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265103

Human EI24 knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

EI24 KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 4. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
1 Images
Sanger Sequencing - Human EI24 knockout HeLa cell line (AB265103)
  • Sanger seq

Unknown

Sanger Sequencing - Human EI24 knockout HeLa cell line (AB265103)

Homozygous : 1 bp insertion in exon 4.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 4

Disease

Adenocarcinoma

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265103-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265103-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab265103 Human EI24 knockout HeLa cell line", "number":"AB265103-CMP01" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265103-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265103 Human EI24 knockout HeLa cell line", "number":"AB265103-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265103-CMP02" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265103-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265103 Human EI24 knockout HeLa cell line", "number":"AB265103-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265103-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265103 Human EI24 knockout HeLa cell line", "number":"AB265103-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
EI24
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

EI24 also known as PIG8 is an apoptosis-inducing factor which has a molecular weight of approximately 24 kDa. It functions mechanically by inducing programmed cell death and is involved in the p53 pathway which is associated with tumor suppression. EI24 is widely expressed in various tissues with higher expression observed in the thymus lymph nodes and spleen.
Biological function summary

The activity of EI24 is significant in regulating apoptosis. It contributes to cellular homeostasis by facilitating the elimination of damaged or unneeded cells. EI24 does not operate as part of any known large protein complexes but it interacts with proteins related to the cell cycle and apoptosis regulation. By promoting apoptosis EI24 helps maintain normal cellular functions and prevents the accumulation of defective cells.

Pathways

Several important biological activities involve EI24. It plays a role in the p53-mediated apoptotic pathway which is critical for responding to DNA damage and other cellular stresses. In this pathway EI24 interacts with the tumor suppressor protein p53 promoting cell death in response to DNA damage. EI24 also associates with Bcl-2 family proteins which influence the apoptotic process. This association suggests a role for EI24 in promoting apoptosis through mitochondrial pathways.

EI24 is linked to certain types of cancer including breast cancer and lymphomas. Altered expression or mutations in the EI24 gene can contribute to tumorigenesis and cancer progression. Studies show that the loss of EI24 function interacts with p53 mutations influencing tumor development and resistance to apoptosis. The role of EI24 in cancer highlights its potential as a target for therapeutic interventions aiming to restore the apoptotic pathways in cancer cells.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com